DarioHealth Corp. announced on August 25, 2025, that a 20-for-1 reverse stock split of its issued and outstanding common stock is expected to be implemented at market open on August 28, 2025. Following the split, the company's common stock will begin trading on the Nasdaq Capital Market on a post-split basis under its existing trading symbol "DRIO," but with a new CUSIP Number.
The reverse stock split will reduce the company's approximately 47,996,572 common shares outstanding to about 2,399,829 shares. The number of authorized shares, 400,000,000, will remain unchanged. Fractional shares resulting from the split will be rounded up to the nearest whole share on a per stockholder basis.
The company's board of directors approved the reverse stock split under authority granted by stockholders at the 2025 Annual Meeting held on July 23, 2025. This corporate action will not impact any stockholder's percentage ownership or voting power, aside from minimal effects related to fractional shares.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.